www.beigene.com
www.brukinsa.com/hcp

Contact Information:

Amy Modean (MN)
651-260-1373
amy.modean@beigene.com

Michele Hayes (ND & SD)
612-518-9167
Michele.hayes@beigene.com

Chris Walton (WI)
414-447-2591
Chris.walton@beigene.com

Return to Virtual Exhibit Hall

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 4,000+ employees in China, the United States, Australia, and Europe are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally-discovered product, BRUKINSA® (zanubrutinib) in the United States.

Dosing Administration Guide 

myBeiGene HCP Brochure

Register for a MCL peer to peer educational program:
Invitation to Zoom Meeting  September 24 - 12:00 P.M. CT